Literature DB >> 293746

Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.

I Gigli, T Fujita, V Nussenzweig.   

Abstract

We recently described the isolation from human serum of a serum protein (C4 binding protein) that functions as an essential cofactor for C3b inactivator in the proteolysis of fluid-phase C4b and to a much lesser extent, C3b. We show here the role of C4 binding protein in the formation and function of the classical pathway C3 convertase (C42). C4 binding protein interferes with the assembly of the membrane-bound C3 convertase of the classical pathway and accelerates the decay of C42 in a dose-dependent fashion. Its removal from serum by means of specific immune absorption promotes the vigorous consumption of C3 after addition of C1; this effect is abolished by reconstitution with purified C4 binding protein. Although C4 binding protein inhibits the hemolytic function of cell-bound C4b, we did not detect any change in the structure of C4b even after prolonged incubations of EAC14 with C4 binding protein. For this reason, and on the basis of studies of the time required for maximal reactivity (Tmax) of cellular intermediates generated in the presence of C4 binding protein and limited amounts of C2, we conclude that the effects of C4 binding protein are probably mediated by displacing C2a from specific binding sites on C4b. In addition, C4 binding protein enhances the cleavage by C3b inactivator of the alpha' chain of cell-bound C4b. When EAC14 cells were incubated with both control proteins, the Tmax of the cells was prolonged and the lysis was markedly diminished. We conclude that C4 binding protein and C3b inactivator control the C3 convertase of the classical pathway in a fashion similar to that described for beta 1H and C3b inactivator in the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 293746      PMCID: PMC411913          DOI: 10.1073/pnas.76.12.6596

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').

Authors:  S Nagasawa; R M Stroud
Journal:  Immunochemistry       Date:  1977 Nov-Dec

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The purification and properties of the second component of human complement.

Authors:  M A Kerr; R R Porter
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

4.  Reversible adsorption of C'2 by EAC'4: role of Mg2+, enumeration of competent SAC'4, two-step nature of C'2a fixation and estimation of its efficiency.

Authors:  G Sitomer; R M Stroud; M M Mayer
Journal:  Immunochemistry       Date:  1966-01

5.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

6.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

7.  Structural and functional differences between the H-2 controlled Ss and Slp proteins.

Authors:  A Ferreira; V Nussenzweig; I Gigli
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

8.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.

Authors:  T Fujita; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

10.  The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.

Authors:  T Fujita; V Nussenzweig
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  96 in total

1.  Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus).

Authors:  Isabell C Pechtl; Robert K Neely; David T F Dryden; Anita C Jones; Paul N Barlow
Journal:  Protein Sci       Date:  2011-12       Impact factor: 6.725

2.  Analysis of binding sites on complement factor I using artificial N-linked glycosylation.

Authors:  Jose I Sanchez-Gallego; Tom W L Groeneveld; Stefanie Krentz; Sara C Nilsson; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

3.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 4.  C4b-binding protein, a regulatory protein of complement.

Authors:  S R Barnum
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 5.  Variation, Indispensability, and Masking in the M protein.

Authors:  Partho Ghosh
Journal:  Trends Microbiol       Date:  2017-08-31       Impact factor: 17.079

6.  Opsonophagocytosis of Chlamydia pneumoniae by Human Monocytes and Neutrophils.

Authors:  Mads Lausen; Mathilde Selmar Pedersen; Nareen Sherzad Kader Rahman; Liv Therese Holm-Nielsen; Faduma Yahya Mohamed Farah; Gunna Christiansen; Svend Birkelund
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

7.  Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.

Authors:  R Martínez-Barricarte; E Goicoechea de Jorge; T Montes; A G Layana; S Rodríguez de Córdoba
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A van Es
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement.

Authors:  F Pardo-Manuel; J Rey-Campos; A Hillarp; B Dahlbäck; S Rodriguez de Cordoba
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.

Authors:  Lena Kask; Bruno O Villoutreix; Mårten Steen; Bala Ramesh; Björn Dahlbäck; Anna M Blom
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.